Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Nam Ha Pharmaceutical Joint Stock Company (OTC: DuocNamHa)
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| 04/12/2022 | Annual report 2021 |
| 03/24/2022 | Audited Parent Company FS 2021 |
| 03/24/2022 | Audited Consolidated FS 2021 |
| 12/30/2021 | Audited FS 2020 |
| 05/28/2021 | Annual report 2020 |
Name: Nam Ha Pharmaceutical Joint Stock Company
Abbreviation:NAPHACO
Address: Số 415 - Hàn Thuyên - Tp.Nam Định - T.Nam Định
Telephone: (84.228) 3649408
Fax: (84.228) 3644650
Email:Info@naphaco.com.vn
Website:https://namhapharma.com
Exchange: OTC
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date:
Chartered capital: 52,000,000,000
Listed shares:
Shares outstanding:
Status: Operating
Tax code:
Establishment license:
Issued date:
Business license: 0703000004
Issued date:
Main business scope:
- Sản xuất Tân Dược, Đong dược
- 1960 tiền thân là công ty Hợp Doanh Ích Hoa Sinh
- Năm 1966 Sát nhập lấy tên là Xí Nghiệp Dược Phẩm Nam Hà
- Tháng 6/1995 Đổi tên thành Công Ty Dược Phẩm Nam Hà
- Tháng 1/2000 chuyển thành CTCP Dược Phẩm Nam Hà
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
